A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/139
A61K 39/395 (2006.01) C07K 16/30 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1339798
This invention provides a use of monoclonal antibody R-24 linked to a chemotherapeutic agent for the treatment of cancer of neuroectodermal origin, epithelial cancer of pigmentation disorder and wherein the chemotherapeutic agent is at least one agent from the group dacarbazine, adriamycin, pimozide, dibromodulcitol, bleomycin, actinomycin D, purine analog, pyrimidine analog, nitrosoureas, cis-platin, radiation-emitting reagent, tumor necrosis factor, interferon, lymphotoxins, interleukin, BCG, and autologous tumor cell vaccine.
499927
Carswell Elizabeth
Cordon-Cardo Carlos
Fliegel Bettina L.
Houghton Alan N.
Melamed Myron R.
Carswell Elizabeth
Cordon-Cardo Carlos
Fliegel Bettina L.
Houghton Alan N.
Melamed Myron R.
LandOfFree
Method for treatment of neuroectodermal malignancies and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of neuroectodermal malignancies and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of neuroectodermal malignancies and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1320349